Results 21 to 30 of about 5,073 (155)

Impact of proper surgical treatment on the survival of patients with epithelial ovary cancer

Revista do Colégio Brasileiro de Cirurgiões, 2022
Objective: to evaluate the quality of surgical treatment of ovarian cancer patients and assess the impact of adequate surgical oncological treatment on disease-free survival and overall survival of patients with advanced epithelial ovarian cancer ...
FLAVIO HENRIQUE FARIA, ANA PAULA DRUMMOND LAGE, ANGÉLICA NOGUEIRA RODRIGUES, ALBERTO JULIUS ALVES WAINSTEIN   +3 more
doaj   +2 more sources

83 Impact of introducing extensive surgical procedures to cytoreductive surgery (CRS) in advanced epithelial ovarian cancer (EOC) on rate of complete debulking (CD) and survival [PDF]

International Journal of Gynecological Cancer, 2019
Objectives To asses the impact of extensive procedures (Diaphragmatic resection, large and small bowel resection, complete peritonectomy, complete omentectomy, paraaortic lmph node dissection, splenectomy, resection of all visible disease) in CRS on the rate of CD, progression free (PFS), and overall survival (OS) in patients with advanced EOC ...
M. Seoud, A. El Housheimi, I. Jaafar, K. Hamed, R. Abdallah, A. Khalil, F. Jamali   +6 more
openaire   +1 more source

En-block cytoreduction for advanced ovarian cancer

Gynecologic Oncology Reports, 2023
The standard treatment of advanced ovarian, fallopian tube and peritoneal cancer is cytoreductive surgery followed by platinum-based chemotherapy (du Bois et al., 2005). This type of cancer expands through the peritoneum, which is the thin and continuous
Anastasios Pandraklakis, Vasilis Mitsopoulos, Ioannis Biliatis   +2 more
doaj   +1 more source

Peritoneal metastases from rare ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)

Pleura and Peritoneum, 2023
There are limited treatment options and no consensus on the management of advanced rare ovarian malignancies. Rare ovarian malignancies can present with peritoneal metastases (PM), featuring a similar presentation to more common ovarian subtypes ...
Falla-Zuniga Luis Felipe, Sardi Armando, King Mary Caitlin, Lopez-Ramirez Felipe, Barakat Philipp, Nieroda Carol, Diaz-Montes Teresa, Gushchin Vadim   +7 more
doaj   +1 more source

Evaluation of the relationship between lactacidemia and postoperative complications after surgery for peritoneal carcinomatosis [PDF]

Korean Journal of Anesthesiology, 2021
Background Cytoreductive surgery was developed as a treatment for peritoneal carcinomatosis. However, this surgery is associated with important complications.
Marta Soriano Hervás, Rosa Játiva-Porcar, Daniel Robles-Hernández, Anna Serra Rubert, Blanca Segarra, Cristina Oliva, Javier Escrig, José Antonio Llueca   +7 more
doaj   +1 more source

A proposal of Brazilian Society of Surgical Oncology (BSSO/SBCO) for standardizing cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) procedures in Brazil: pseudomixoma peritonei, appendiceal tumors and malignant peritoneal mesothelioma [PDF]

Revista do Colégio Brasileiro de Cirurgiões, 2017
ABSTRACT Cytoreductive surgery plus hypertermic intraperitoneal chemotherapy has emerged as a major comprehensive treatment of peritoneal malignancies and is currently the standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome as well as malignant peritoneal mesothelioma.
Batista, Thales Paulo, Sarmento, Bruno José Queiroz, Loureiro, Janina Ferreira, Petruzziello, Andrea, Lopes, Ademar, Santos, Cassio Cortez, Quadros, Cláudio de Almeida, Akaishi, Eduardo Hiroshi, Cordeiro, Eduardo Zanella, Coimbra, Felipe José Fernández, Laporte, Gustavo Andreazza, Castro, Leonaldson Santos, Batista, Ranyell Matheus Spencer Sobreira, Aguiar Júnior, Samuel, Costa Júnior, Wilson Luiz, Ferreira, Fábio Oliveira   +15 more
openaire   +4 more sources

Therapeutic approaches in patients with bone metastasis due to endometrial carcinoma – A systematic review

Journal of Bone Oncology, 2023
Background: Bone metastases (BM) are uncommon in endometrial carcinoma (EC), without information on the optimal oncologic management of patients with BM in EC. Here, we systematically review clinical characteristics, treatment approaches and prognosis in
Martin Heidinger, Elisa Simonnet, Li Mei Koh, Brigitte Frey Tirri, Marcus Vetter   +4 more
doaj   +1 more source

Perioperative management of cytoreductive surgery and hyperthermic intraoperative thoraco-abdominal chemotherapy (HITAC) for pseudomyxoma peritonei

Indian Journal of Anaesthesia, 2019
Peritoneal carcinomatosis is intraperitoneal spread of gastrointestinal and gynaecological cancers. Cytoreductive surgeries and hyperthermic intraperitoneal chemotherapy offers survival benefits in these cases.
Sohan Lal Solanki, Jhanvi S Bajaj, Febin Rahman, Avanish P Saklani   +3 more
doaj   +1 more source

Society of Onco-Anaesthesia and Perioperative Care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC)

Indian Journal of Anaesthesia, 2019
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) for primary peritoneal malignancies or peritoneal spread of malignant neoplasm is being done at many centres worldwide.
Sohan Lal Solanki, Sudipta Mukherjee, Vandana Agarwal, Raghu S Thota, Kalpana Balakrishnan, Shagun Bhatia Shah, Neha Desai, Rakesh Garg, Reshma P Ambulkar, Nitin Madhukar Bhorkar, Viplab Patro, Snita Sinukumar, Meenakshi V Venketeswaran, Malini P Joshi, Rajesh Holalu Chikkalingegowda, Vijaya Gottumukkala, Pascal Owusu-Agyemang, Avanish P Saklani, Sanket Sharad Mehta, Ramakrishnan Ayloor Seshadri, John C Bell, Sushma Bhatnagar, Jigeeshu V Divatia   +22 more
doaj   +1 more source

Does the Performance of Splenectomy as Part of Cytoreductive Surgery Carry a Worse Prognosis Than in Patients Not Receiving Splenectomy? A Propensity Score Analysis and Review of the Literature

Journal of Investigative Surgery, 2022
Background & Objectives Ultra-radical (UR) procedures, including splenectomy, are utilized to increase complete cytoreduction rates during Cytoreductive Surgery (CRS) performed with the aim of complete macroscopic clearance of disease.
James Davies, Viren Asher, Anish Bali, Summi Abdul, Andrew Phillips   +4 more
doaj   +1 more source